Human Molecular Genetics, 2003, Vol. 12, No. 3 273-281
© 2003 Oxford University Press
Mismatch repair gene Msh2 modifies the timing of early disease in HdhQ111 striatum
1Molecular Neurogenetics Unit, Massachusetts General Hospital, Charlestown, MA 02129, USA and 2Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Received September 19, 2002; Accepted November 18, 2002
Somatic instability of expanded HD CAG repeats that encode the polyglutamine tract in mutant huntingtin has been implicated in the striatal selectivity of Huntington's disease (HD) pathology. Here in HdhQ111 mice, we have tested whether a genetic background deficient in Msh2, expected to eliminate the unstable behavior of the 109 CAG array inserted into the murine HD gene, would alter the timing or striatal specificity of a dominant disease phenotype that predicts late-onset neurodegeneration. Our analyses of HdhQ111/+:Msh2+/+ and HdhQ111/+: Msh2-/- progeny revealed that, while inherited instability involved Msh2-dependent and -independent mechanisms, lack of Msh2 was sufficient to abrogate progressive HD CAG repeat expansion in striatum. The absence of Msh2 also eliminated striatal mutant huntingtin with somatically expanded glutamine tracts and caused an 
5 month delay in nuclear mutant protein accumulation, but did not alter the striatal specificity of this early phenotype. Thus, somatic HD CAG instability appears to be a consequence of a striatal-selective disease process that accelerates the timing of an early disease phenotype, via expansion of the glutamine tract in mutant huntingtin. Therefore Msh2, as a striking modifier of early disease onset in a precise genetic HD mouse model, provides a novel target for the development of pharmacological agents that aim to slow pathogenesis in man.
* To whom correspondence should be addressed at: Molecular Neurogenetics Unit, Building 149, 13th St, Charlestown, MA 02129, USA. Tel.: +1 6177265726; Fax: +1 6177265736; Email: wheeler{at}helix.mgh.harvard.edu
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Gray, D. I. Shirasaki, C. Cepeda, V. M. Andre, B. Wilburn, X.-H. Lu, J. Tao, I. Yamazaki, S.-H. Li, Y. E. Sun, et al. Full-Length Human Mutant Huntingtin with a Stable Polyglutamine Repeat Can Elicit Progressive and Selective Neuropathogenesis in BACHD Mice J. Neurosci., June 11, 2008; 28(24): 6182 - 6195. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Gonitel, H. Moffitt, K. Sathasivam, B. Woodman, P. J. Detloff, R. L. M. Faull, and G. P. Bates DNA instability in postmitotic neurons PNAS, March 4, 2008; 105(9): 3467 - 3472. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V C Wheeler, F Persichetti, S M McNeil, J S Mysore, S S Mysore, M E MacDonald, R H Myers, J F Gusella, N S Wexler, and The US Venezuela Collaborative Research Group Factors associated with HD CAG repeat instability in Huntington disease J. Med. Genet., November 1, 2007; 44(11): 695 - 701. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Lloret, E. Dragileva, A. Teed, J. Espinola, E. Fossale, T. Gillis, E. Lopez, R. H. Myers, M. E. MacDonald, and V. C. Wheeler Genetic background modifies nuclear mutant huntingtin accumulation and HD CAG repeat instability in Huntington's disease knock-in mice Hum. Mol. Genet., June 15, 2006; 15(12): 2015 - 2024. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Pelletier, B. T. Farrell, J. J. Miret, and R. S. Lahue Mechanistic features of CAG*CTG repeat contractions in cultured cells revealed by a novel genetic assay Nucleic Acids Res., September 30, 2005; 33(17): 5667 - 5676. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bhattacharyya and R. S. Lahue Srs2 Helicase of Saccharomyces cerevisiae Selectively Unwinds Triplet Repeat DNA J. Biol. Chem., September 30, 2005; 280(39): 33311 - 33317. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. D. Wells, R. Dere, M. L. Hebert, M. Napierala, and L. S. Son Advances in mechanisms of genetic instability related to hereditary neurological diseases Nucleic Acids Res., July 8, 2005; 33(12): 3785 - 3798. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I.V. Kovtun, A.R. Thornhill, and C.T. McMurray Somatic deletion events occur during early embryonic development and modify the extent of CAG expansion in subsequent generations Hum. Mol. Genet., December 15, 2004; 13(24): 3057 - 3068. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Gomes-Pereira and D. G. Monckton Chemically induced increases and decreases in the rate of expansion of a CAG{middle dot}CTG triplet repeat Nucleic Acids Res., May 20, 2004; 32(9): 2865 - 2872. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Savouret, C. Garcia-Cordier, J. Megret, H. te Riele, C. Junien, and G. Gourdon MSH2-Dependent Germinal CTG Repeat Expansions Are Produced Continuously in Spermatogonia from DM1 Transgenic Mice Mol. Cell. Biol., January 15, 2004; 24(2): 629 - 637. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Kennedy, E. Evans, C.-M. Chen, L. Craven, P. J. Detloff, M. Ennis, and P. F. Shelbourne Dramatic tissue-specific mutation length increases are an early molecular event in Huntington disease pathogenesis Hum. Mol. Genet., December 15, 2003; 12(24): 3359 - 3367. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Watase, K. J. T. Venken, Y. Sun, H. T. Orr, and H. Y. Zoghbi Regional differences of somatic CAG repeat instability do not account for selective neuronal vulnerability in a knock-in mouse model of SCA1 Hum. Mol. Genet., November 1, 2003; 12(21): 2789 - 2795. [Abstract] [Full Text] [PDF]
|
|